EVFM

Evofem Biosciences, Inc. Common Stock
EVFM

Overview Fund Activity
Delisted

EVFM was delisted on the 10th of August, 2022.

Back to rankings

71 hedge funds and large institutions have $19.8M invested in Evofem Biosciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
-10
Holders Change %
-12.35%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
13
Reduced
19
Closed
20
Calls
$2.04M
Puts
$611K
Net Calls
+$1.43M
Net Calls Change
+$136K

Top Buyers

1
Fuller & Thaler Asset Management
1
Fuller & Thaler Asset Management
California
$798K
2
BlackRock
2
BlackRock
New York
$2.86M
3
Bank of America
3
Bank of America
North Carolina
$179K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$991K
5
SW
5
SteelPeak Wealth
California
$44K

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$144K
2
Millennium Management
2
Millennium Management
New York
$480K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$0
4
HA
4
Heartland Advisors
Wisconsin
$0
5
TWMP
5
Taylor Wealth Management Partners
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
76
Deutsche Bank
Germany
– -$11K -643 Closed
CAPTRUST Financial Advisors
77
CAPTRUST Financial Advisors
North Carolina
– -$1K -84 Closed
Citigroup
78
Citigroup
New York
– -$1K -67 Closed
New York State Common Retirement Fund
79
New York State Common Retirement Fund
New York
– -$1K -46 Closed
1 2 3
4